Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mymd Pharmaceuticals Inc
(NQ:
MYMD
)
1.820
UNCHANGED
Last Price
Updated: 3:38 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mymd Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia
January 05, 2022
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase Agreement for Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccine to be Commercialized in Southeast Asia
December 29, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals to Participate in Two Investor Conferences During December 2021
December 01, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
51 Biggest Movers From Yesterday
December 28, 2021
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to...
Via
Benzinga
MyMD Pharmaceuticals Announces Issuance of U.S. Patent Covering Lead Drug Candidate MYMD-1 in a Method of Extending Lifespan
November 23, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
68 Biggest Movers From Wednesday
November 26, 2021
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share. Longeveron Inc. (...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
MyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business Development in Latin America
November 18, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
November 16, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
Super CBD To the Rescue? This Company Thinks So
November 11, 2021
Photo by Kindel Media from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation
October 26, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21
October 19, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
A First-of-its-Kind Drug Candidate Targeting the Root Causes of Aging Could Soon Dominate Estimated $600 Billion Aging Market
October 18, 2021
Image on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga....
Via
Benzinga
Cramer Likes Azek And SoFi, But Said Owning This Stock Could Be Dreadful
October 08, 2021
On CNBC's "Mad Money Light...
Via
Benzinga
Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show
October 06, 2021
Benzinga is thrilled to announce the guest lineup for our next All Access show, set to air Thursday, October 7 at 9:00 am ET. Thursday's Guest Lineup The theme...
Via
Benzinga
MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7
October 05, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD
September 22, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
September 13, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals to Present its Novel Therapeutic Platforms for Extending Healthy Lifespan at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
September 09, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Use of Lead Candidate MYMD-1 for Treating Fibrosis and Asthma
August 24, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Announces Issuance of U.S. Patent for Synthetic Cannabinoid Compounds for Treating Neuroinflammatory and Neurodegenerative Diseases
August 10, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
85 Biggest Movers From Yesterday
August 11, 2021
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...
Via
Benzinga
MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine
August 10, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharma Stock Is Trading Higher As COVID-19 Candidate Effective In Suppressing Cytokine Storm
August 05, 2021
MyMD Pharmaceuticals Inc (NASDAQ: MYMD) announces that a human cell research study of its lead compound MYMD-1 found the drug to effectively suppress the cytokine storm...
Via
Benzinga
Exposures
COVID-19
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study
August 05, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shows Commonality in Comparative Study with FDA-Approved Anti-Inflammatory and Anti-Autoimmune Drugs Used for Arthritis, Colitis and Dermatitis
July 27, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1
July 07, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 16, 2021
Gainers Satsuma Pharmaceuticals (NASDAQ:STSA
Via
Benzinga
MyMD Pharmaceuticals Set to Join Russell Microcap® Index
June 07, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Appoints David Rini, Professor at the Johns Hopkins School of Medicine, to Scientific Advisory Board
May 17, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals Schedules Business Update Conference Call
May 12, 2021
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.